|
At the American Society of Clinical Oncology (ASCO) 2012, Suresh Ramalingam, MD, Associate Professor, Chief of Thoracic Oncology, Director, Medical Oncology, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, discusses ganetespib. Ganetespib is a potent, synthetic, small molecule inhibitor of Hsp90, a chaperone protein that is essential to the function of certain other proteins that drive the growth, proliferation, and survival of many different types of cancer. |